Rodino-Klapac Louise — SEC insider filings

SEC reporting owner CIK 1836218. 30 insider filings on record with FilingPulse; latest filed 2026-09-08.

Transaction summary — filings shown

Covers all 30 filings on record, filed 2020-12-14 to 2026-09-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Sarepta Therapeutics, Inc. (SRPT)President, R&D and Tech Ops301 leg · 3,780 sh · $299,867—55

Insider filings — Rodino-Klapac Louise

FiledFormIssuerReported transactionsSource
2026-09-084Sarepta Therapeutics, Inc. (SRPT)Tax withholding (F): 21,423 @ $22.22EDGAR
2026-03-134Sarepta Therapeutics, Inc. (SRPT)Tax withholding (F): 948 @ $17.03EDGAR
2026-03-114Sarepta Therapeutics, Inc. (SRPT)Tax withholding (F): 504 @ $16.95 · Tax withholding (F): 895 @ $16.95EDGAR
2026-03-034Sarepta Therapeutics, Inc. (SRPT)Option exercise (M): 8,125 · Tax withholding (F): 3,718 @ $16.20 · Tax withholding (F): 767 @ $16.20 · Option exercise (M): 8,125 (derivative) @ $0EDGAR
2026-02-274Sarepta Therapeutics, Inc. (SRPT)Grant/award (A): 1,875 (derivative)EDGAR
2025-11-194Sarepta Therapeutics, Inc. (SRPT)Tax withholding (F): 4,582 @ $18.42EDGAR
2025-09-054Sarepta Therapeutics, Inc. (SRPT)Grant/award (A): 93,875 @ $0 · Grant/award (A): 50,000 @ $0EDGAR
2025-08-064Sarepta Therapeutics, Inc. (SRPT)Grant/award (A): 6,250 (derivative) @ $0EDGAR
2025-03-114Sarepta Therapeutics, Inc. (SRPT)Option exercise (M): 5,500 · Tax withholding (F): 924 @ $100.13 · Tax withholding (F): 2,539 @ $100.13 · Grant/award (A): 8,276 · Option exercise (M): 5,500 (derivative) @ $0 · Grant/award (A): 16,644 (derivative) @ $0EDGAR
2025-03-104Sarepta Therapeutics, Inc. (SRPT)Option exercise (M): 17,500 · Tax withholding (F): 514 @ $103.70 · Tax withholding (F): 7,990 @ $103.70 · Option exercise (M): 17,500 (derivative) @ $0EDGAR
2025-03-064Sarepta Therapeutics, Inc. (SRPT)Tax withholding (F): 1,704 @ $101.34EDGAR
2025-03-044Sarepta Therapeutics, Inc. (SRPT)Tax withholding (F): 715 @ $103.77EDGAR
2025-02-134Sarepta Therapeutics, Inc. (SRPT)Grant/award (A): 3,500 (derivative) @ $0EDGAR
2024-11-204Sarepta Therapeutics, Inc. (SRPT)Tax withholding (F): 4,558 @ $102.89EDGAR
2024-06-254Sarepta Therapeutics, Inc. (SRPT)Option exercise (M): 6,250 · Tax withholding (F): 2,182 @ $164.64 · Grant/award (A): 5,500 (derivative) @ $0 · Grant/award (A): 6,250 (derivative) @ $0 · Option exercise (M): 6,250 (derivative) @ $0EDGAR
2024-03-114Sarepta Therapeutics, Inc. (SRPT)Tax withholding (F): 512 @ $120.49 · Tax withholding (F): 909 @ $123.14EDGAR
2024-03-064Sarepta Therapeutics, Inc. (SRPT)Tax withholding (F): 1,728 @ $125.32EDGAR
2024-03-054Sarepta Therapeutics, Inc. (SRPT)Tax withholding (F): 778 @ $126.19 · Grant/award (A): 6,000 @ $0 · Grant/award (A): 12,500 (derivative) @ $0EDGAR
2023-11-204Sarepta Therapeutics, Inc. (SRPT)Tax withholding (F): 4,508 @ $82.98EDGAR
2023-03-104Sarepta Therapeutics, Inc. (SRPT)Tax withholding (F): 912 @ $153.19EDGAR
2023-03-084Sarepta Therapeutics, Inc. (SRPT)Tax withholding (F): 1,134 @ $157.21 · Grant/award (A): 4,500 @ $0 · Grant/award (A): 27,000 (derivative) @ $0EDGAR
2023-03-034Sarepta Therapeutics, Inc. (SRPT)Tax withholding (F): 522 @ $147.57EDGAR
2022-11-214Sarepta Therapeutics, Inc. (SRPT)Tax withholding (F): 4,211 @ $108.52EDGAR
2022-03-084Sarepta Therapeutics, Inc. (SRPT)Tax withholding (F): 1,216 @ $79.20 · Grant/award (A): 8,000 @ $0 · Grant/award (A): 48,000 (derivative) @ $0EDGAR
2022-03-014Sarepta Therapeutics, Inc. (SRPT)Tax withholding (F): 572 @ $75.05EDGAR
2021-11-294Sarepta Therapeutics, Inc. (SRPT)Purchase (P): 3,780 @ $79.33EDGAR
2021-11-174Sarepta Therapeutics, Inc. (SRPT)Grant/award (A): 40,000 @ $0EDGAR
2021-03-104/ASarepta Therapeutics, Inc. (SRPT)Tax withholding (F): 565 @ $86.97 · Grant/award (A): 15,000 @ $0EDGAR
2021-03-054Sarepta Therapeutics, Inc. (SRPT)Grant/award (A): 15,000 @ $0 · Grant/award (A): 60,000 (derivative) @ $0EDGAR
2020-12-144Sarepta Therapeutics, Inc. (SRPT)Grant/award (A): 25,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-12-09 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1836218 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs